Access to the latest research — for scientists and people living with PD alike — in PDF's new scientific journal.
FDA Approves New Drug to Treat Low Blood Pressure in Parkinsonís
- Feb 19 2014
Yesterday, the US Food and Drug Administration (FDA) approved a new medication, called droxidopa (Northera™), to treat a form of low blood pressure affecting people with certain conditions including Parkinson's disease. The condition is called neurogenic orthostatic hypotension (NOH).
Neurogenic orthostatic hypotension is a sharp drop in blood pressure that occurs when a person gets up from bed or from a chair, and it is caused by a failure of the peripheral nervous system. It can cause dizziness, falls or even loss of consciousness. Previously, no effective treatment options were available to ease its symptoms.
PDF welcomes the addition of this new tool for clinicians and people with Parkinson’s disease to use to manage symptoms of NOH. For specific information on this drug, including side effects and dosing, please contact PDF's HelpLine at (800) 457-6676, and check back soon for our updated medication fact sheet. Browse PDF's previous article on this medication here and read the official statement from the FDA at the link below.
Source Date: Feb 19 2014